A nomogram for predicting severe myelosuppression in small cell lung cancer patients following the first-line chemotherapy
Abstract This study aimed at establishing and validating a nomogram to predict the probability of severe myelosuppression in small cell lung cancer (SCLC) patients following the first-line chemotherapy. A total of 179 SCLC cases were screened as the training group and another 124 patients were used...
Main Authors: | Yaoyuan Li, Yanju Bao, Honggang Zheng, Yinggang Qin, Baojin Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-42725-7 |
Similar Items
-
Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer
by: Ziming Zheng, et al.
Published: (2022-09-01) -
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
by: Kyemyung Park, et al.
Published: (2022-04-01) -
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
by: Lito E. Papanicolas, et al.
Published: (2021-05-01) -
Comparison of Different Time Nutritional Intervention on Chemotherapy-induced Ⅳ Degree Myelosuppression in Cancer Patients
by: QI Xiaoguang, et al.
Published: (2018-01-01) -
Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
by: Mengqi Cheng, et al.
Published: (2021-08-01)